Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CAY 10526

Known as: CAY-10526, CAY10526 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
COX‐2 and its product PGE2 enhance carcinogenesis and tumor progression, which has been previously reported in melanoma. As most… Expand
2016
2016
COX-2 and its product PGE2 enhance carcinogenesis and tumor progression, which has been previously reported in melanoma. As most… Expand
2014
2014
Prostaglandin E2 (PGE2) involves in progression of various chronic inflammation-related cancers including cholangiocarcinoma (CCA… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
2012
2012
Cyclooxygenase (COX)-2 expression and release of prostaglandins (PGs) by macrophages are consistent features of… Expand
  • figure 2
  • figure 3
  • figure 6
  • figure 8
  • figure 7
2012
2012
The aim of this study was to investigate the expression and significance of microsomal prostaglandin synthase-1 (mPGES-1) and… Expand
  • table 2
  • table 1
  • table 3
  • table 4
  • figure 1
2010
2010
Prostaglandin E2 (PGE2), which is synthesized by many cell types, has a cytoprotective effect in the gastrointestinal tract and… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2